ACRF Centre for Translational Cancer Therapeutics and Imaging
Sophisticated imaging technologies to explore cancer biology
Ms. Kerryn Westcott
03 9496 5512
You need to login or register to bookmark/favorite this content.
Post author: Kerryn Westcott. Last update: 02/11/2015 at 10:53 am by Kerryn Westcott.
The ACRF Centre for Translational Cancer Therapeutics and Imaging is an innovative venture bringing together the Olivia Newton-John Cancer Research Institute, the University of Melbourne, Austin Health, and the Melbourne Brain Centre in a multi-disciplinary approach to explore the fundamental biology of cancer utilising sophisticated imaging technologies. Through world class clinical and pre-clinical researchers, and providing a resource for research training in cancer molecular imaging, the ACRF Centre will be at the cutting edge of translational cancer research. It will aid trials of novel therapies to be conducted in Australia, enhancing the prospects for cancer patients not only in Australia, but worldwide.
The ACRF Centre for Translational Cancer Therapeutics and Imaging includes a Mediso Nanoscan Pet/MRI Imaging Platform, a Mediso Nanoscan SPECT/CT Imaging Platform and an IVIS Spectrum Bioluminescent and Fluorescence Imaging Unit. This equipment is available for use by all those wishing to make use of the technology.
The Centre will benefit Australian cancer sufferers by significantly increasing the understanding of the underlying causes of cancer, while exploring new therapeutic approaches to the treatment of the disease. The Australian Cancer Research Foundation (ACRF) cancer research grant program is dedicated to funding world-class research in Australia that has the power to make significant break-throughs in cancer diagnosis and treatment.
Through world class research, collaboration between clinical and pre-clinical researchers, and providing a resource for research training in cancer molecular imaging, the ACRF Centre will be at the cutting edge of translational cancer research. It will ultimately aid trials of novel therapies to be conducted in Australia, enhancing the prospects for cancer patients not only in Australia, but worldwide.
Potential new users are required to submit an application for use of the imaging equipment and review the Standard Operating Procedures. If you require an application form please send an email to the ACRF Centre Project Manager indicating which equipment you are considering for your research.
Access by fee for service
Access by users external to managing organisation, Access by users internal to managing organisation
ACRF Centre for Translational Cancer Therapeutics and Imaging
Olivia Newton-John Cancer Research Institute. Level 5, Olivia Newton-John Cancer and Wellness Centre, 145 Studley Rd, Heidelberg, Victoria, Australia.
View location in Google maps.
Type: Core facility in a research organisation
Discipline areas: Biological Science
Precinct: Northern
Affiliations: Austin Health, Olivia Newton-John Cancer Research Institute, The University of Melbourne
Biological Science categories: Animal models, Bio-Assay, Bioresources, CT, Fluorescence, In-vivo image analysis, In-vivo imaging, Luminescence, Microscopy, Mouse, MRI, Mulit-modal, Optical, PET, Rat, Small animal
